Brief: Gt Biopharma says That Co Has Until Feb 20, 2024, To Regain Nasdaq Minimum Bid Price Requirement Rule
Aug 22 (Reuters) - GT Biopharma Inc GTBP.O :
* GT BIOPHARMA INC- GOT NOTICE FROM NASDAQ THAT CO HAS UNTIL
FEB
20, 2024, TO REGAIN COMPLIANCE WITH MINIMUM BID PRICE
REQUIREMENT RULE
Source text for Eikon: ID:
Further company coverage: GTBP.O
((Reuters.Briefs@thomsonreuters.com;))